PP
ASTH icon

Paloma Partners’s Astrana Health ASTH Stock Holding History

Paloma Partners’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,800
Closed -$220K – 1129
2024
Q3 		$220K Buy
+3,800
New +$187K 0.01% 932
2019
Q1 		– Sell
-17,036
Closed -$338K – 1995
2018
Q4 		$338K Sell
17,036
-34,888
-67% -$653K 0.01% 823
2018
Q3 		$1.15M Buy
+51,924
New +$1.09M 0.02% 679

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners's ASTH Position: Q4 2024 in Review

Paloma Partners sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 3,800 shares — an estimated $220K sold.

Paloma Partners first reported a position in ASTH in Q3 2018 and held it in 3 quarters. The position peaked at $1.15M in Q3 2018. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Paloma Partners reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 3,800 Astrana Health shares in Q4 2024, an estimated $220K.
  • Paloma Partners first reported a position in Astrana Health in Q3 2018 and held it in 3 quarters.
  • Paloma Partners's Astrana Health position peaked at $1.15M in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.